MOLECULAR PSYCHIATRY, published by SpringerNature, is a premier peer-reviewed journal that has established itself as a leading platform for the dissemination of cutting-edge research in the fields of neuroscience, molecular biology, and psychiatry. With an impressive impact factor and a reputation for excellence, the journal is ranked Q1 in key categories, signifying its high academic quality and relevance. The journal’s scope spans groundbreaking studies and innovative therapeutic approaches that intersect at the molecular and cellular levels, providing invaluable insights into the biological underpinnings of psychiatric disorders. Since its inception in 1996, MOLECULAR PSYCHIATRY has evolved to support both established and emerging researchers, fostering a collaborative environment that enhances the understanding of mental health. It is committed to improving access to scientific knowledge, although it currently does not offer open access options. With its headquarters in London, the journal continues to play a pivotal role in enhancing the global dialogue on psychiatric and neurological advancements, making it an essential resource for academics and professionals dedicated to advancing mental health sciences.

Research in Autism Spectrum Disorders, an esteemed journal published by ELSEVIER SCI LTD, is dedicated to advancing the understanding of autism spectrum disorders through innovative research and scholarly articles. Since its inception in 2007, the journal has carved out a distinguished place in the field, reflected in its robust 2023 Impact Factor and Q2 ranking in key categories such as Clinical Psychology, Developmental and Educational Psychology, and Psychiatry and Mental Health. By bridging the gap between research and practice, this journal serves as a vital resource for researchers, professionals, and students alike, fostering collaboration and knowledge-sharing among those dedicated to improving outcomes for individuals with autism. Featuring a broad scope that encompasses various aspects of autism research, the journal remains committed to publishing high-quality studies that drive the conversation forward in this critical area of study. Access options for the journal's content are available under the Elsevier guidelines, ensuring that pivotal research reaches a wide audience.

PSYCHIATRIC GENETICS, published by LIPPINCOTT WILLIAMS & WILKINS, is a pivotal journal dedicated to the interdisciplinary study of genetic factors in psychiatric disorders, bridging the fields of genetics, psychiatry, and neuroscience. With a commitment to advancing research from its inception in 1990 and continuing through 2024, the journal provides a platform for innovative studies and findings that explore the genetic underpinnings of mental health. Although not currently an Open Access publication, it reaches a wide audience concerned with the complex interplay between genetics and psychiatric conditions, contributing to its Q3 and Q2 quartile rankings across multiple relevant categories in 2023. The importance of this journal cannot be understated; it serves as a crucial resource for researchers, clinicians, and students eager to uncover insights that could lead to more effective interventions and treatments in the realm of mental health.

Advances in Neurodevelopmental Disorders is a leading peer-reviewed journal published by SpringerNature, focusing on the critical intersection of psychology and social sciences as they pertain to neurodevelopmental disorders. With its ISSN 2366-7532 and E-ISSN 2366-7540, this journal has carved out a significant niche since its inception in 2017, particularly recognized for its influence in academia, evident from its category quartiles in 2023, which rank it Q3 in Psychology and Q2 in Social Sciences. The journal is committed to disseminating innovative research and knowledge that advance our understanding of neurodevelopmental disorders, making it an essential resource for researchers, professionals, and students dedicated to this field. With increasing citations and a respectable Scopus ranking—#209 in Social Sciences and #46 in Psychology—the journal continues to foster interdisciplinary dialogue and scientific advancement. Based in the Netherlands and published out of London, it offers a platform for open access to significant findings and discussions related to neurodevelopmental challenges, addressing a vital area of health that impacts individuals and families worldwide.

GENES BRAIN AND BEHAVIOR is a leading journal published by Wiley that focuses on the intricate interplay between genetic factors and behavioral neuroscience. With a robust ISSN of 1601-1848 and an E-ISSN of 1601-183X, this journal serves as a premier platform for innovative research that spans across multiple fields including genetics, neurology, and behavioral neuroscience. Recognized for its significant impact with a 2023 categorization of Q1 in Behavioral Neuroscience and Q2 in both Genetics and Neurology, GENES BRAIN AND BEHAVIOR asserts itself as an influential resource for scholars, practitioners, and students alike, facilitating the advancement of knowledge in these dynamic areas. Its Scopus rankings underscore its prominence—ranking #18 in Behavioral Neuroscience and #45 in Neurology, placing it in the top percentiles among its peers. Although not an open-access journal, the rigorous peer-review process ensures high-quality publications, pivotal for those pursuing cutting-edge research and applications. With a history of convergence from 2002 to 2024, this journal continues to foster academic dialogue and discovery in the ever-evolving landscape of brain and behavioral studies.

Autism Research, published by WILEY, is a premier academic journal dedicated to advancing the understanding of autism spectrum disorders (ASD) through high-quality research and clinical studies. With the ISSN 1939-3792 and E-ISSN 1939-3806, this journal has been integral to the field since its inception in 2008 and has been consistently ranked in the Q1 quartile across categories such as Genetics (clinical), Neurology (clinical), and various facets of Neuroscience. Holding prominent Scopus ranks, including #18 in Genetics (clinical) and #26 in General Neuroscience, Autism Research provides a vital platform for researchers, clinicians, and students alike to disseminate innovative findings and foster collaborations aimed at improving diagnosis and treatment strategies for individuals with autism. While not an open access journal, it offers a blend of insightful articles and impactful research that is essential for professionals seeking to stay at the forefront of this rapidly evolving field.

Psychiatry and Clinical Psychopharmacology, an open-access journal published by AVES since 2017, is dedicated to advancing the fields of psychiatric medicine and psychopharmacology. With an ISSN of 2475-0573 and an E-ISSN of 2475-0581, this journal aims to provide a platform for disseminating innovative research and clinical findings relevant to mental health professionals and researchers. Although it currently holds a Q3 ranking in Pharmacology (medical) and a Q4 ranking in Psychiatry and Mental Health according to the 2023 category quartiles, the journal has established itself as a significant contributor to evolving discussions in these critical fields. Based in the United Kingdom, the journal encompasses diverse topics, ranging from pharmacological treatments to novel therapeutic approaches in psychiatry, thereby appealing to a broad audience of clinicians, scientists, and students. The open-access model ensures that all research is readily available, fostering an environment of collaboration and knowledge-sharing as the journal converges until 2024 to encompass the latest advancements in both pharmacology and clinical psychopharmacology.

BRAIN & DEVELOPMENT is a prestigious academic journal published by ELSEVIER, renowned for its pivotal contributions to the fields of developmental neuroscience, neurology, and pediatrics. Established in 1979, this journal has become an essential resource for researchers and clinicians alike, as it explores the complexities of brain development and associated neurological disorders in children. With an impactful focus on advancing scientific understanding, BRAIN & DEVELOPMENT is currently ranked in the Q3 quartile in Developmental Neuroscience and Clinical Neurology and Q2 in Pediatrics, reflecting its significance within the medical community. Its ISSN 0387-7604 and E-ISSN 1872-7131 underline its established presence in academic literature. While the journal does not offer open access options, it continues to be a key platform for disseminating new research findings and fostering innovation in the understanding of pediatric neurological health. The journal's commitment to quality research is further evidenced by its ongoing publication trajectory up until 2024, making it a vital source of knowledge for students, professionals, and educators in related fields.

Developmental Neurorehabilitation is an esteemed journal published by Taylor & Francis Inc, dedicated to advancing the field of developmental neuroscience and rehabilitation. With an ISSN of 1751-8423 and an E-ISSN of 1751-8431, this journal serves as a vital resource for researchers, clinicians, and students interested in innovative therapeutic approaches and rehabilitation techniques for children and adolescents. Since its inception in 1997, Developmental Neurorehabilitation has focused on disseminating high-quality research, contributing to a deeper understanding of recovery processes in developmental disorders, and facilitating interdisciplinary dialogue among professionals. With its recognition in Q2 and Q3 quartiles across prominent categories such as Pediatrics and Rehabilitation, it stands out as a pivotal publication in its field, boasting Scopus rankings that reflect its significant impact—ranked #53 in Rehabilitation and #139 in Pediatrics, among others. While maintaining a commitment to quality research, the journal does not currently offer open access but remains accessible through institutional subscriptions, further enriching the academic landscape with critical insights into rehabilitation methodologies for developmental challenges and promoting better clinical practices to improve patient outcomes.

NEUROBIOLOGY OF DISEASE is a premier journal dedicated to advancing the understanding of neurological disorders and the underlying biological processes, published by Academic Press Inc, Elsevier Science. With an impressive impact factor indicative of its significance—ranked in the Q1 quartile in Neurology for 2023 and occupying the 14th rank out of 192 journals in the field of Neuroscience and Neurology—this journal serves as a critical resource for researchers, clinicians, and students alike. The journal has a rich history since its inception in 1994, continuously evolving its scope to encompass groundbreaking research and insights into neurobiological mechanisms and disease pathology. Though it currently does not provide Open Access options, NEUROBIOLOGY OF DISEASE remains a vital vessel for disseminating knowledge that significantly contributes to the field of neurology, fostering an understanding that can lead to innovative therapeutic strategies.